spacer
home > pmps > summer 2018 > driving digitalisation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Driving Digitalisation

Pharmaceutical manufacturers are faced with the task of bringing new drugs to market as quickly as possible, without any compromise on quality or patient safety. A key driver of this demand is the time pressure faced in relation to the expiry of patents. Therefore, manufacturers need to move from R&D to production in the shortest possible time with minimum investment. Digitalisation and the adoption of emerging industrial digital technologies are set to play key parts in the delivery of such objectives.

Digitalisation is the technology focus behind Industry 4.0, and the central message about how it can enhance manufacturing and production capabilities is gaining steady traction. Advocates say its data-driven, highly connected world of seamless technology platforms will drive productivity improvements, promote agile production, aid competitiveness, and, ultimately, build business value and boost economic success.

The recent publication of the government-backed Made Smarter Review has set out a clear road map for the wide-scale adoption of emerging industrial digitalisation technologies and articulates how this can have a significant and positive economic impact. This includes a predicted £455 billion boost for the UK’s manufacturing base, an increase in manufacturing sector growth of up to 3% per annum, a net gain of 175,000 jobs, and a reduction of CO2 emissions by 4.5%.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Alwyn Jones has over 20 years’ experience in automation and engineering, working with market-leading companies, supplying systems and solutions into the highly regulated industry sectors. At Siemens, he is Head of Pharmaceutical and Life Sciences and manages the UK and Ireland pharmaceutical and life sciences sector strategy, helping manufacturers bring new and affordable drugs to market in the shortest possible time, without any compromise on quality.
spacer
Alwyn Jones
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

BioIVT Introduces New Quality Management System to Maintain Highest Quality Biospecimens and Drug Development Research Services

BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it is introducing a new internal cloud-based Quality Management System (QMS), Master Control. This new standardized, ISO compliant QMS will help BioIVT manage documentation, auditing, supplier and customer accounts, and risk across all locations. It will consolidate and replace a variety of computer- and paper-based document control systems located at existing and newly-acquired BioIVT sites in the US, Europe and Asia.
More info >>

White Papers

What is process characterization?

EXPUTEC

Process characterization is an essential step in the commercialization of a new (biological) drug. For drug product commercialization, manufacturers must validate the drug’s manufacturing process. This ensures that the manufacturing process delivers consistently a quality product and that the patient is not at risk.
More info >>

 
Industry Events

6th Annual Single Cell Analysis Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its 6th Annual Single Cell Analysis Congress taking place on 8-9 November 2018 in London.  Part of the Genomics & Synthetic Biology Series UK, the congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement